Hybrid Event | 23 - 25 May 2023
Steigenberger Wiltcher's, Brussels
Wednesday 24 May 2023
Regulatory Frameworks: Implications of Legislative Revision and Market Access Pathways
Prepare For The Impact Of The Biggest Shake-Up Of Pharmaceutical Policy And Legislation With The EU Commission, European Medicines Agency (EMA), And Key Pharmaceutical Stakeholders
Benchmark Your Regulatory Legal Progress With Real World Insights On Key Pharmaceutical Legal Issues:
Industry Impact the EU Pharmaceutical Legislation Revision:
- Novel Incentives: Vouchers And Beyond - What Is Needed?
- Examining Proposed Changes To The Paediatric Regulation
- New Updates On Regulatory Data Protection
- Changes To Orphan Market Exclusivity
New Developments in Regulatory Frameworks:
- Legal Requirement And Obligations For Your Supply Chain
- Reshaping Clinical Research With Health Data
- Using IVDs In Clinical Trials - How To Ensure Compliance
- Artificial Intelligence Act And New Rules Surrounding AI Liability Directive
Evolving Pharmaceutical Market Access Frameworks:
- Examine EU Joint HTA processes and the interaction with national EU processes
- Will faster marketing authorizations lead to faster reimbursement?
- Ilap: new market access pathway in the UK
- Innovative healthcare systems solutions and market access strategies
Introducing the Regulatory Frameworks Speaker line up: